Chanock; Robert M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chanock; Robert M..The latest application filed is for "construction of west nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by west nile virus".

Company Profile

5.26.13

Chanock; Robert M. - Bethesda MD
Chanock; Robert M. - formerly of Bethesda MD
Chanock; Robert M. - Betheseda MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Grant 11,400,150 - Pletnev , et al. August 2, 2	2022-08-02
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus App 20210069317 - Pletnev; Alexander G. ; et al.	2021-03-11
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Grant 10,869,920 - Pletnev , et al. December 22, 2	2020-12-22
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile App 20200030435 - Pletnev; Alexander G. ; et al.	2020-01-30
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Grant 10,456,461 - Pletnev , et al. Oc	2019-10-29
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus App 20180369358 - Pletnev; Alexander G. ; et al.	2018-12-27
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Grant 10,058,602 - Pletnev , et al. August 28, 2	2018-08-28
Construction Of West Nile Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused By West Nile Virus App 20140294892 - Pletnev; Alexander G. ; et al.	2014-10-02
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus Grant 8,778,671 - Pletnev , et al. July 15, 2	2014-07-15
Neutralizing monoclonal antibodies to respiratory syncytial virus Grant 8,221,759 - Pilkington , et al. July 17, 2	2012-07-17
Hexavalent bovine rotavirus reassortant composition designed for use in developing countries Grant 8,168,202 - Kapikian , et al. May 1, 2	2012-05-01
Neutralizing Monoclonal Antibodies To Respiratory Syncytial Virus App 20120087909 - Pilkington; Glenn R. ; et al.	2012-04-12
Multivalent human-bovine rotavirus vaccine Grant 7,932,074 - Kapikian , et al. April 26, 2	2011-04-26
Neutralizing monoclonal antibodies to respiratory syncytial virus App 20090110684 - Pilkington; Glenn R. ; et al.	2009-04-30
Neutralizing monoclonal antibodies to respiratory syncytial virus Grant 7,488,477 - Pilkington , et al. February 10, 2	2009-02-10
Hexavalent Bovine Rotavirus Reassortant Composition Designed for Use in Developing Countries App 20080292660 - Kapikian; Albert Z. ; et al.	2008-11-27
Human neutralizing monoclonal antibodies to respiratory syncytial virus Grant 7,364,737 - Burton , et al. April 29, 2	2008-04-29
Attenuated human rotavirus vaccine Grant 7,150,984 - Hoshino , et al. December 19, 2	2006-12-19
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus App 20050100886 - Pletnev, Alexander G. ; et al.	2005-05-12
Human neutralizing monoclonal antibodies to respiratory syncytial virus App 20040234528 - Burton, Dennis R. ; et al.	2004-11-25
Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions App 20040223981 - Kapikian, Albert Z. ; et al.	2004-11-11
Full-length infectious cDNA clones of tick borne flavivirus Grant 6,794,174 - Pletnev , et al. September 21, 2	2004-09-21
Full-length infectious cDNA clones of tick borne flavivirus App 20040033594 - Pletnev, Alexander ; et al.	2004-02-19
Human neutralizing monoclonal antibodies to respiratory syncytial virus Grant 6,685,942 - Burton , et al. February 3, 2	2004-02-03
Chimeric and/or growth-restricted flaviviruses Grant 6,676,936 - Lai , et al. January 13, 2	2004-01-13
Neutralizing monoclonal antibodies to respiratory syncytial virus App 20040005324 - Pilkington, Glenn R. ; et al.	2004-01-08
Attenuated Human Rotavirus Vaccine App 20020058043 - HOSHINO, YASUTAKA ; et al.	2002-05-16
Chimeric and/or growth-restricted flaviviruses Grant 6,184,024 - Lai , et al. February 6, 2	2001-02-06
Attenuated respiratory syncytial virus vaccine compositions Grant 5,922,326 - Murphy , et al. July 13, 1	1999-07-13
Attenuated respiratory syncytial virus vaccine compositions Grant 5,882,651 - Murphy , et al. March 16, 1	1999-03-16
Human neutralizing monoclonal antibodies to respiratory syncytial virus Grant 5,762,905 - Burton , et al. June 9, 1	1998-06-09
Vaccine against rotavirus diseases and method of preparing same Grant 4,927,628 - Chanock , et al. May 22, 1	1990-05-22
Vaccine against rotavirus diseases Grant 4,751,080 - Wyatt , et al. June 14, 1	1988-06-14
Vaccine against rotavirus diseases Grant 4,704,275 - Wyatt , et al. November 3, 1	1987-11-03
Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors Grant 4,571,385 - Greenberg , et al. February 18, 1	1986-02-18
Human use of avian-human reassortants as vaccines for influenza A virus Grant 4,552,758 - Murphy , et al. November 12, 1	1985-11-12
Cultivatable human rotavirus type 2 Grant 4,341,870 - Wyatt , et al. July 27, 1	1982-07-27
Temperature-sensitive recombinant mutant viruses and a process for producing same Grant 3,992,522 - Chanock , et al. November 16, 1	1976-11-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.